Charts

(Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Petros Pharmaceuticals, Inc. ("Petros," or the "Company") (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter ...

(Please see important safety information below)

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PTPI stock results show that Petros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. The post PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers MSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap ...

Nitrate patients subgroup demonstrated 100% correct self-selection when utilizing the web app technology with the drug facts label compared to 40% when using drug facts label alone (among 86% vs. 56% of all users) underscoring the significant potential benefits of technology assistance in an OTC setting

Petros begins enrollment in AI integrated Human Factors Study to optimize self-screening, continuing its efforts to make STENDRA (avanafil) the first erectile dysfunction medication to achieve OTC Status

AI software expected to further enable Petros's efforts to make STENDRA the first ED product to be offered over the counter

Gainers SINTX Techs (NASDAQ:SINT) shares increased by 75.0% to $0.41 during Tuesday's after-market session. The market value of their ...

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported ...

Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) shares rose sharply in today’s pre-market trading as the company posted ...

Gainers Inspire Veterinary (NASDAQ:IVP) stock moved upwards by 37.5% to $0.26 during Thursday's after-market session. The market value ...

FDA requests meeting to review the Company's technology component and discuss further development and requirements

Gainers Talphera (NASDAQ:TLPH) stock moved upwards by 10.5% to $0.85 during Wednesday's after-market session. The company's market cap ...

Over 78% of technology-enabled subjects correctly self-selected vs. 56% using drug facts label alone demonstrating continued progress toward STENDRA® working to become the first erectile dysfunction medication to successfully achieve OTC status NEW ...

Over 78% of technology-enabled subjects correctly self-selected vs. 56% using drug facts label alone demonstrating continued progress toward STENDRA® working to become the first erectile dysfunction medication to successfully achieve OTC status

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA ...

Human Factor Study represents important component of FDA requirements for technology to pave way for STENDRA OTC approval

Idea Evolver is the only provider to successfully complete Actual Use Trial for FDA review for Rx-to-OTC Switch Approval

Idea Evolver is the only provider to successfully complete Actual Use Trial for FDA review for Rx-to-OTC Switch Approval

New AI/machine learning tool designed to help potential users more effectively self-select in the effort to make STENDRA the first erectile dysfunction (ED) medication available OTC

Gainers SeaStar Medical Holding (NASDAQ:ICU) shares moved upwards by 42.7% to $1.1 during Thursday's pre-market session. The company's ...

Important step towards STENDRA potentially becoming the first erectile dysfunction medication to successfully achieve OTC Status

Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock rose 132.2% to $0.92 during Friday's pre-market session. The company's market cap stands at ...

Company well positioned to continue collaboration with FDA toward pursuit of OTC pathway for STENDRA

Gainers Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares rose 72.4% to $0.2930 in pre-market trading after falling 15% on ...

NEW YORK, NY / ACCESSWIRE / September 28, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a company focused on expanding consumer access to medication through over the counter (OTC) pathway, announces today that Fady Boctor, President and Chief Commercial Officer, will present a corporate overview at the LD Micro Main Event XVI. The conference is being held on October 3 - 5, 2023 at the Luxe Sunset Boulevard Hotel in Los Angeles.

Gainers NovaBay Pharmaceuticals (AMEX:NBY) stock rose 109.7% to $1.3 during Monday's pre-market session. The company's market cap ...

NEW YORK, NY / ACCESSWIRE / September 11, 2023 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over the counter (OTC) pathway provides the below Letter to Shareholders:

NEW YORK, NY / ACCESSWIRE / September 6, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a pioneer in expanding consumer access to medication through over the counter (OTC) pathways, announces today that Fady Boctor, President and Chief Commercial Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 - 13, 2023 at the Lotte New York Palace Hotel.

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 89.5% to $0.5 during Monday's after-market session. At the close, ...

Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

Provides Update on Progress Toward Over the Counter (non-prescription) Development of STENDRA

Gainers Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 106.8% to $5.77 in pre-market trading. The stock began trading on a 1:18 ...

Gainers Healthcare Triangle (NASDAQ:HCTI) stock rose 109.2% to $6.82 during Wednesday's regular session. Healthcare Triangle's stock is ...

Gainers Avrobio (NASDAQ:AVRO) stock rose 11.9% to $1.22 during Wednesday's pre-market session. The company's market cap stands at $53.8 ...

Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), the award-winning maker of multi-stream collaboration solutions, today appointed two new directors to its board. Jonathan Schechter, Partner, The Special Equities Group, and Robert Weinstein, Chief Financial Officer, Synaptogenix, Inc. have joined Oblong’s board of directors. In addition, Jim Lusk and Matthew Blumberg have retired from the Oblong board.

Gainers AN2 Therapeutics (NASDAQ:ANTX) stock moved upwards by 23.0% to $6.71 during Tuesday's regular session. The company's market cap ...

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the ...

Gainers Virios Therapeutics, Inc. (NASDAQ: VIRI) shares jumped 103.5% to $1.2746 after the company announced initial FDA feedback ...

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market ...